Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Keryx Biopharmaceuticals, Inc.
(NQ:
KERX
)
8.188
USD
+0.528 (+6.89%)
Streaming Delayed Price
/ Updated:
12:36 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Keryx Biopharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Keryx Biopharmaceuticals Rising on Above-Average Volume, Consistent With Trend (KERX)
Today 10:58 EDT
from
Comtex SmarTrend® News Briefs
Notable Analyst Rating Changes 06/19: (CX) (ADBE) (LINE) Upgraded; (CLF) (S) (BBRY) Downgraded
Today 10:30 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8431101 for the full story.
Read More
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTEK) Lower (more...)
Today 9:30 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8430817 for the full story.
Read More
from
StreetInsider.com News Articles
JPMorgan Starts Keryx Biopharmaceuticals (KERX) at Overweight
Today 8:20 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8430256 for the full story.
Read More
from
StreetInsider.com News Articles
GSK, AZN, KERX, and RPTP Early Briefing and Review
June 07, 2013
from
ACCESSWIRE
Keryx (KERX) Will Present Updated Zerenex Phase 3 Data
June 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8384401 for the full story.
Read More
from
StreetInsider.com News Articles
Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31, 2013
Investors considering a purchase of Keryx Biopharmaceuticals Inc. (KERX) shares, but tentative about paying the going market price of $8.14/share, might benefit from considering selling puts among the...
Read More
category
Dividends
from
Dividend Channel
Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31, 2013
Investors considering a purchase of Keryx Biopharmaceuticals Inc. (KERX) shares, but tentative about paying the going market price of $8.14/share, might benefit from considering selling puts among the...
Read More
category
Stocks
from
Market News Video
Keryx Biopharmaceuticals Earnings Hindsight: Up 0.6% in Last 13 Days (KERX)
May 20, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Oppenheimer Raises PT on Keryx Biopharmaceuticals Following Management Meetings
May 17, 2013
In a report published Friday, Oppenheimer analyst Boris Peaker reiterated an Outperform rating on Keryx Biopharmaceuticals (NASDAQ: KERX ), and slightly raised the price target from $11.00 to $12.00....
Read More
category
Oppenheimer
,
KERX
,
Benzinga
, and 3 more.
from
Latest Articles from Benzinga.com
KERX, ARIA, PDLI added to BioStock Watch List at GSR
May 14, 2013
from
ACCESSWIRE
Trading Alert for Keryx Biopharmaceuticals
May 13, 2013
NEW YORK (AVAFIN) -- Trading of Keryx Biopharmaceuticals options resulted in establishing a new ...
Read More
from
AVAFIN
Keryx Biopharmaceuticals, Inc. (KERX) Posts Mixed Q1 Results
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8314080 for the full story.
Read More
from
StreetInsider.com News Articles
Grab KERX 7.9% Cheaper Than Its Secondary?
May 02, 2013
Looking back to 92 days ago, Keryx Biopharmaceuticals Inc. (KERX) priced a 8,234,000 share secondary stock offering at $8.49 per share.
Read More
category
Stocks
from
Market News Video
GSK, AZN, KERX, and RPTP Early Briefing and Review
May 02, 2013
from
ACCESSWIRE
Illumina and Other Bargain Biotech Stocks Worth a Look Now
May 01, 2013
The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list...
Read More
category
SHPG
,
amgen
,
Benzinga
, and 31 more.
from
Latest Articles from Benzinga.com
Traders Favorite: Keryx Biopharmaceuticals, McDonald's Corporation, Merck & Co, Hertz Global Holdings
April 22, 2013
from
ACCESSWIRE
Radian Group Inc. And Keryx Biopharmaceuticals News: (NYSE: RDN), (NASDAQ; KERX)
April 22, 2013
from
ACCESSWIRE
Keryx Biopharma (KERX) Stockholder BlackRock (BLK) Raises Stake to 10.5%
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8245501 for the full story.
Read More
from
StreetInsider.com News Articles
Patent Expert To Discuss Keryx's Zerenex
April 09, 2013
A Seeking Alpha contributor will host a conference call with a patent expert to discuss Keryx Biopharmaceutical Inc.'s (Nasdaq: KERX) Zerenex lifting the stock price 76 cents to close at $8.10....
Read More
from
MarketMinute.com Stock News
Higher Close In Anticipation Of Earnings
April 09, 2013
Investors lifted the markets to a higher close with the Dow climbing 59 points to 14,673 in anticipation of strong earnings. Nasdaq gained 15 points to 3237.
Read More
category
Market News
from
MarketMinute.com Market Updates
Mid-Afternoon Market Update: Markets Continue to Rally, First Solar Skyrockets
April 09, 2013
Toward the end of trading Tuesday, the Dow traded up 0.57 percent to 14,696.98 while the NASDAQ rose 0.69 percent to 3,244.44. The S&P also rose, increasing 0.54 percent to 1,571.51. Index Technicals:...
Read More
category
Earnings
,
OPK
,
Benzinga
, and 18 more.
from
Latest Articles from Benzinga.com
Mid-Day Market Update: Markets Heading Upwards, MGIC Investment Drops
April 09, 2013
Midway through trading Tuesday, the Dow traded up 0.37 percent to 14,666.98 while the NASDAQ rose 0.27 percent to 3,231.44. The S&P also rose, increasing 0.28 percent to 1,567.51. Index Technicals: The...
Read More
category
Earnings
,
Benzinga
,
Movers
, and 18 more.
from
Latest Articles from Benzinga.com
NASDAQ:RPRX and NASDAQ:AMRN added to Biotech Stock Watch List
March 28, 2013
from
ACCESSWIRE
BioStock Watch List Initiated with (NASDAQ:SVA) and (NASDAQ:KERX)
March 14, 2013
from
ACCESSWIRE
Brean Reiterates Buy on Keryx Biopharmaceuticals (KERX)
March 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8178082 for the full story.
Read More
from
StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. (KERX ) Misses Q4 EPS by 1c
March 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8174627 for the full story.
Read More
from
StreetInsider.com News Articles
Trading Radar for 03/12: Costco (COST), Bon-Ton (BONT), Majesco (COOL), Velti (VELT) Report
March 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173878 for the full story.
Read More
from
StreetInsider.com News Articles
Cramer's Homework: Steer Clear of These 2 Troubled Stocks
March 08, 2013
Sometimes Jim Cramer tells a caller that he needs to do homework before he can make a decision on a stock. And he's not kidding. Following is Cramer's research.
Read More
category
Keryx Biopharmaceuticals Inc
,
tvcodes/tvearn
,
tvcodes/tvearnings
, and 16 more.
from
CNBC.com News
Insights on Block and Options Trading Activity for Keryx Biopharmaceuticals (KERX)
March 06, 2013
NEW YORK (AVAFIN) -- Institutional trading of Keryx Biopharmaceuticals shares yielded a bought/sold volume ...
Read More
from
AVAFIN
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here